Schedule 13G ownership disclosure

ADC THERAPEUTICS SA

Common Shares · CUSIP: H0036K147

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Oaktree Fund Administration, LLC

    Shares: 4,673,441 · Class: 4.14%

  • Oaktree Capital Holdings, LLC

    Shares: 4,673,441 · Class: 4.14%

  • Oaktree Capital Group Holdings GP, LLC

    Shares: 4,673,441 · Class: 4.14%

  • Brookfield Asset Management ULC

    Shares: 0 · Class: 0%

  • Brookfield Corporation

    Shares: 0 · Class: 0%

  • Brookfield Asset Management, Ltd.

    Shares: 0 · Class: 0%

  • BAM Partners Trust

    Shares: 0 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-25-040534
Form type
SCHEDULE 13G/A
Filer
ADC Therapeutics SA
CIK
CIK 1771910
Filed
Nov 05, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub